Dostawa rosyjskiej szczepionki Sputnik V na Węgry

EN_01454558_0008

30,00 EUR Private use
Making print for private purpose, storage in computer memory, no distribution rights.
40,00 EUR Internet - private use
Strictly for editorial, single use on a personal (nonprofit) web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.
75,00 EUR Internet commercial use
Strictly for editorial, single use on a commercial web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.
90,00 EUR Print use
Strictly for editorial, single use, inside of newspaper, magazine, book (including digital version), one edition, one single country. Not for resale.

Gross prices

caption

6390758 19.11.2020 In this handout photo released by Hungarian Foreign Ministry, a logo of Russian Direct Investment Fund is pictured on a pack of Russia's coronavirus vaccine Gam-COVID-Vac, trade-named Sputnik V, delivered to Budapest, Hungary. The vaccine is delivered to Hungary to complete clinical trials and finalize the local licensing process. It's possible that Hungary will launch domestic production of the Russian vaccine. Editorial use only, no archive, no commercial use. Hungarian Foreign Ministry

headline Dostawa rosyjskiej szczepionki Sputnik V na Węgry

created date 2020-11-19

credit SPUTNIK Russia/East News

source SPUTNIK Russia

byline

original transmission reference 6390758_5fb69d05415a4

weight 4,22MB

size 32cm x 21cm by 300dpi

keywords - Show

11, 19, 2020, A, AND, ARCHIVE, BUDAPEST, BY, CLINICAL, COMMERCIAL, COMPLETE, CORONAVIRUS, COVID, COVID-19, DELIVERED, DIRECT, DISEASE, DOMESTIC, EDITORIAL, EPIDEMIC, FINALIZE, FOREIGN, FUND, GAM-COVID-VAC, HANDOUT, HUNGARIAN, HUNGARY, IN, INFECTION, INVESTMENT, IS, IT, LAUNCH, LICENSING, LOCAL, LOGO, MINISTRY, NO, OF, ON, ONLY, PACK, PANDEMIC, PICTURED, POSSIBLE, PROCESS, PRODUCTION, RELEASED, RUSSIA, RUSSIAN, SARS-COV-2, SPUTNIK, THAT, THE, THIS, TO, TRADE-NAMED, TRIALS, USE, V, VACCINE, VIRUS, WILL,